Epicore BioNetworks Inc. Announces New Board Director



    CALGARY, Oct. 20 /CNW/ - The Board of Directors of Epicore BioNetworks
Inc. is pleased to announce a new director has joined the board, effective
October 15, 2008. The Board welcomes Mr. Michael Perrault of Montreal, Quebec,
Canada.
    Mr. Perrault is co-founder and president of Simpler Networks Inc of
Montreal, Canada. He has twenty-five years experience in business development
and operations management in the technology field. He has raised over
$100 million in financing for his start-up companies. Mr. Perrault holds an
honors degree in engineering and a master's degree in business administration
from McGill University. The Board expects that his knowledge and experience,
particularly in the area of strategic partnerships will be of great benefit to
Epicore as it embarks on a more aggressive business development program.
    The Board of Directors has approved issuance to Mr. Perrault of 150,000
options to buy Epicore common shares, pursuant to the terms of the Company's
stock option program. The shares will be priced at Cdn $0.10 per share.

    Epicore BioNetworks Inc. is a leading producer of environmental
biotechnology and animal nutrition products. It manufactures in the USA and
markets worldwide to a variety of industries to reduce environmental pollution
and increase operational productivity.
    Epicore BioNetworks Inc. is a public corporation with a registered office
in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange
(symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.)

    This press release contains forward-looking statements that involve
significant risks and uncertainties. The actual results, performance or
achievements of the Company might differ materially from the results,
performance or achievements of the Company expressed or implied by such
forward-looking statements. Such forward-looking statements include, without
limitation, those regarding the development plans of the Company and the
expected timing and results of such development. We can provide no assurance
that such development will proceed as currently anticipated or that the
expected timing or results of such development will be realized. We are
subject to various risks, including the uncertainties of product development,
markets for our products and regulatory review, our need for additional
capital to fund our operations, our reliance on collaborative partners, our
history of losses, and other risks inherent in the biotechnology industry.





For further information:

For further information: Mr. William P. Long, (Chief Executive Officer),
Tel: (609) 267-9118


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890